- Home
- DYN vs BLX Comparison
DYN vs BLX Comparison
Compare DYN & BLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DYN | BLX |
|---|---|---|
| Founded | 1984 | 1977 |
| Country | United States | Panama |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | DYN | BLX |
|---|---|---|
| Price | $19.27 | $44.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $40.25 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 120.2K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 5.55% |
| EPS Growth | N/A | ★ 9.67 |
| EPS | N/A | ★ 6.00 |
| Revenue | N/A | ★ $308,426,000.00 |
| Revenue This Year | N/A | $18.35 |
| Revenue Next Year | N/A | $6.56 |
| P/E Ratio | ★ N/A | $7.50 |
| Revenue Growth | N/A | ★ 10.24 |
| 52 Week Low | $6.36 | $31.14 |
| 52 Week High | $28.96 | $48.38 |
Technical Indicators
Market Signals| Indicator | DYN | BLX |
|---|---|---|
| Relative Strength Index (RSI) | 47.44 | 51.88 |
| Support Level | $18.21 | $44.39 |
| Resistance Level | $23.96 | $45.74 |
| Average True Range (ATR) | 1.55 | 0.69 |
| MACD | -0.30 | 0.04 |
| Stochastic Oscillator | 18.09 | 48.97 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About BLX Banco Latinoamericano de Comercio Exterior S.A.
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.